⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
prnewswire.com
AMGN
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
prnewswire.com
AMGN
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
prnewswire.com
AMGN
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
prnewswire.com
AMGN
LUNGevity Foundation Launches Multi-Year Research Program within Its Small Cell Lung Cancer Initiative
prnewswire.com
AMGN
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS
prnewswire.com
AMGN
NORD and Amgen Launch Learning Collaborative to Improve Rare Disease Diagnosis and Care
prnewswire.com
AMGN
AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026
prnewswire.com
AMGN
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
prnewswire.com
INCY
PRTH
BHC
ACRS
PFE
AMGN
BMY
VERU
LLY
MRK
ABBV
LUNGevity Foundation Launches Every Breath Forward℠ to Advance Progress and Improve Lives Nationwide
prnewswire.com
BIIB
AZN
JNJ
AMGN
LLY
MRK
REGN